David Feldker has been appointed chief executive officer and president of Reliable Biopharmaceutical Corp. (RBC). Mike Zaleski will be stepping down as RBC’s president and chief executive officer, effective October 22, 2010 but will remain an advisor to the board of directors during the transition. Mr. Feldker was previously vice president SAFC at Sigma-Aldrich Corp., responsible for the API contract development and manufacturing segment. “David built SAFC Pharma into one of the leading devel...